A 16-week trial involving children with type 1 diabetes (T1D) found glucose level was in the target range for a greater percentage of time in individuals who used a closed-loop system compared with ...
During a session at AdvaMed’s annual MedTech Conference in Boston this fall, when asked which areas of medtech are currently looking most exciting from an R&D perspective, Medtronic CEO Geoff Martha ...
Please provide your email address to receive an email when new articles are posted on . The use of closed-loop insulin delivery conferred a 10.99% higher time in range than standard of care for ...
Compared with sensor-augmented pump therapy, closed-loop insulin delivery increased glucose time in range and reduced hypoglycemia episodes but detracted from sleep quality. First-generation ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback